Controversies in the management of adjuvant breast cancer with taxanes: Review of the current literature
To access this article, please choose from the options below
PII: S0305-7372(10)00107-6
doi:10.1016/j.ctrv.2010.06.002
© 2010 Elsevier Ltd. All rights reserved.
